Emina Huang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emina huang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emina Huang Today - Breaking & Trending Today

North Texas Man Beats Colon Cancer – NBC 5 Dallas-Fort Worth

A man from North Texas was able to beat deadly colorectal cancer that is increasingly found in young people. ....

United States , Chris Lopez , Emina Huang , Simmons Cancer Center , Fort Worthfor Apple , North Texas ,

Potential Target For Ulcerative Colitis Drugs


Potential Target For Ulcerative Colitis Drugs
by Pooja Shete on 
January 15, 2021 at 7:36 PM
The study conducted by researchers from Cleveland Clinic s Lerner Research Institute is published in the journal
Nature Communications.
The researchers used this model to identify a promising target that could be blocked to slow the disease progression. Ulcerative colitis occurs due to abnormal reactions of the immune system that lead to inflammation and ulcers on the inner lining of the large intestines. The condition is highly heterogeneous both in terms of patients symptoms and disease pathology.
Current therapy for ulcerative colitis mainly focuses on suppressing the overactive immune response with anti-inflammatory drugs. However, these therapies have limited long-term efficacy in ulcerative colitis patients. ....

Emina Huang , Nature Communications , Cleveland Clinic Lerner Research Institute , Cleveland Clinic , Lerner Research Institute , Cancer Biology , Colorectal Surgery , Colitis Patients More Prone , Toxicityulcerative Colitisdrugs Banned , Ulcerative Colitis , Immune System , Chronic Inflammatory Bowel Disease , Anti Ulcerative Colitis Drugs , இயற்கை தகவல்தொடர்புகள் , கிளீவ்லேண்ட் சிகிச்சையகம் லெர்னர் ஆராய்ச்சி நிறுவனம் , கிளீவ்லேண்ட் சிகிச்சையகம் , லெர்னர் ஆராய்ச்சி நிறுவனம் , புற்றுநோய் உயிரியல் , பெருங்குடல் அறுவை சிகிச்சை , பெருங்குடல் அழற்சி நோயாளிகள் மேலும் ப்ரோந் , நோய் எதிர்ப்பு சக்தி அமைப்பு , நாள்பட்ட அழற்சி குடல் நோய் ,

Researchers engineer novel disease model to identify potential targets for ulcerative colitis drugs


CLEVELAND - As reported in
Nature Communications, researchers from Cleveland Clinic s Lerner Research Institute have developed a novel, patient-derived model of ulcerative colitis, which will help advance studies into new treatments for the chronic inflammatory bowel disease.
The team used the model to identify a promising target that could be inhibited to slow disease progression.
Ulcerative colitis is characterized by abnormal reactions of the immune system that lead to inflammation and ulcers on the inner lining of the large intestines. It is a highly heterogeneous condition, both in terms of patients symptoms and disease pathology.
Suppressing the overactive immune response with anti-inflammatory drugs is the current mainstay treatment for inflammatory bowel diseases, although these therapies have limited long-term efficacy in ulcerative colitis patients. ....

United States , Emina Huang , Samaneh Sarvestani , Nature Communications , National Institutes Of Health , Cleveland Clinic Lerner Research Institute , American Society Of Colorectal Surgeons , Surgery Institute At Cleveland Clinic , Cleveland Clinic , Lerner Research Institute , Cancer Biology , Colorectal Surgery , National Institutes , American Society , Digestive Disease , Surgery Institute , Cell Biology , Medicine Health , Clinical Trials , Immunology Allergies Asthma , Internal Medicine , Pharmaceutical Science , ஒன்றுபட்டது மாநிலங்களில் , இயற்கை தகவல்தொடர்புகள் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , கிளீவ்லேண்ட் சிகிச்சையகம் லெர்னர் ஆராய்ச்சி நிறுவனம் ,